Key result
Visceral obesity in CVD patients was associated with 1.75 and 1.43 times greater epicardial deposit thickness of the left and right ventricles, respectively, compared to those without.
Why the study?
The study sought to determine the relationship between epicardial and perivascular adipose tissue thickness and the adipokine-cytokine profile in patients with coronary heart disease to aid cardiovascular disease prediction.
Does visceral obesity correlate with increased epicardial and perivascular adipose tissue thickness and an altered adipokine-cytokine profile in patients with coronary heart disease?
Observational (n=84)
Does visceral obesity correlate with increased epicardial and perivascular adipose tissue thickness and an altered adipokine-cytokine profile in patients with coronary heart disease?
In patients with coronary heart disease, visceral obesity is associated with increased epicardial and perivascular adipose tissue thickness and a pro-inflammatory adipokine-cytokine profile.
Associated with heightened inflammation in CAD with visceral obesity; hypothesis-generating for epicardial fat as biomarker, needs prospective validation.
The aim of this study was to determine the relationship between the thickness of epicardial adipose tissue (EAT) and perivascular adipose tissue (PVAT) and the adipokine-cytokine profile of patients with coronary heart disease, which can be of significant importance for predicting the course of cardiovascular disease (CVD). Eighty-four patients with CVD were assessed and divided into two groups based on the presence of visceral obesity (VO). In patients with VO, the thickness of the epicardial deposits of the left and right ventricles were 1.75 and 1.43 times greater, respectively, than in patients without VO. For patients with VO, the prevalence of the volume of the left anterior descending artery was 10% higher, and the middle third of the envelope artery was 28% higher, when compared to patients without VO. When evaluating inflammatory status, it was established that the concentration of tumor necrosis factor-α, interleukin (IL)-1β, and leptin in the blood serum of patients with VO exceeded the values of patients without VO. The level of anti-inflammatory IL-10 was 2-times lower in patients with VO. The findings of this study show that increased EAT and PVAT are independent risk factors of CVD, as well as a possible model for the assessment of drug effectiveness for CVD.
No takes yet. Share an insight, caveat, or question.
Груздева et al. (2019) conducted an observational in Coronary heart disease (n=84). Visceral obesity vs. No visceral obesity was evaluated on Thickness of epicardial and perivascular adipose tissue and adipokine-cytokine profile. Visceral obesity in CVD patients was associated with 1.75 and 1.43 times greater epicardial deposit thickness of the left and right ventricles, respectively, compared to those without.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: